Product Pipeline
Highlights

Most advanced-stage TB product candidates

Related links:

Product Pipeline


Clinical Development
Product Target Indication Research & Discovery Pre-Clinical Phase I Phase II Phase III Approved
for Market
TB Patch Diagnosis of active TB Clinical Development - Phase III
SQ109 Treatment of TB Clinical Development - Phase I
Drug Compliance Monitor Device for application in multiple drug therapies Pre-Clinical
SQ609 Crohn's disease, TB, SARS, other anti-viral Research & Discovery
SQ641 TB, other anti-infective Research & Discovery

* In vitro diagnostic; non-clinical regulatory.

Clinical Trials

The recently completed clinical trial of our TB Patch diagnostic and the Phase I study of a new TB antibiotic, SQ109, demonstrate our commitment to the commercialization of new products for diseases of epidemic potential.  Sequella will address important unmet medical needs for a broad range of infectious diseases in the future.
Home | Company Overview | Science | Product Pipeline | Media Center | Site Map
© 2006 Sequella, Inc.